Page last updated: 2024-09-02

caffeic acid phenethyl ester and Cholangiocarcinoma

caffeic acid phenethyl ester has been researched along with Cholangiocarcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alpini, G; Alvaro, D; DeMorrow, S; Franchitto, A; Francis, H; Gaudio, E; Kopriva, S; Mancinelli, R; Onori, P; Savage, J; Ueno, Y; Venter, J1

Other Studies

1 other study(ies) available for caffeic acid phenethyl ester and Cholangiocarcinoma

ArticleYear
Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-kappaB and induction of apoptosis.
    International journal of cancer, 2009, Aug-01, Volume: 125, Issue:3

    Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers, Tumor; Caffeic Acids; Cell Cycle; Cholangiocarcinoma; Cytotoxins; Dimethyl Sulfoxide; DNA; Down-Regulation; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Humans; Liver; Mice; Mice, Inbred BALB C; Mice, Nude; NF-kappa B; Organ Size; Phenylethyl Alcohol; Proliferating Cell Nuclear Antigen; Signal Transduction; Transcription Factor RelA; Transplantation, Heterologous; Up-Regulation

2009